Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™-1 and -2)
Obesity (Silver Spring). 2024 Nov 4. doi: 10.1002/oby.24184. Online ahead of print. ABSTRACT OBJECTIVE: The objective of this study was to describe the rationale and …